{{Rsnum
|rsid=11857176
|Chromosome=15
|position=77872364
|Orientation=plus
|GMAF=0.483
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 13.3 | 50.4 | 36.3
| HCB | 20.4 | 46.7 | 32.8
| JPT | 20.4 | 49.6 | 30.1
| YRI | 61.2 | 36.1 | 2.7
| ASW | 52.6 | 38.6 | 8.8
| CHB | 20.4 | 46.7 | 32.8
| CHD | 25.7 | 50.5 | 23.9
| GIH | 6.9 | 34.7 | 58.4
| LWK | 47.3 | 44.5 | 8.2
| MEX | 24.1 | 55.2 | 20.7
| MKK | 26.9 | 52.6 | 20.5
| TSI | 16.7 | 52.0 | 31.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=8E-7
  |OR=1.80
  |ORtxt=[1.127-2.874]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}